Published On : December 2017 Pages : 150 Category: Medical Devices Report Code : HC12407
Industry Outlook and Trend Analysis
The Allergy Diagnostics Market was worth USD billion in the year of 2017 and is expected to reach approximately USD billion by 2023, while registering itself at a compound annual growth rate (CAGR) of % during the forecast period. Allergy is fundamentally referred to a hypersensitivity medical issue associated with the immune system, where the system responds with foreign particles, otherwise called allergen. Different side effects of sensitivity incorporate red eyes, hives, eczema, itchiness, runny nose, and even, in serious cases, asthma attack. Sensitivity analytic administrations help in recognizing sorts of hypersensitivities, and subsequently deciding treatment regimen as for particular allergic conditions. Increasing aged population, surge in healthcare expenditure in developing as well as developed economies, and rise in environmental pollution level are foreseen to drive the market development. The quickly changing ways of life of individuals are coming about into health issue, for example, sensitivities, accordingly driving interest for analytic blood tests, for example in-vitro and in-vivo tests. However, strict directions and approaches forced by the administrations, and tremendous capital speculation required for establishment of analytic hardware associated with allergic disorders are foreseen to obstruct development of the market.
Product Outlook and Trend Analysis
On the basis of product type the market is segmented into Instruments, Assay Kits, Consumables and services. Assay kits are foreseen to remain favored among products in the market, trailed by instruments. Nonetheless, sales of consumables are anticipated to reflect a relatively higher CAGR in the upcoming years.
End User outlook and Trend Analysis
On the basis of end user the market is segmented into Hospital, Academic Research Institutes and Diagnostic Laboratories. Hospitals are foreseen to be the fastest developing end user section. In 2022, a major share of the overall market was held by hospitals. Additionally, hospitals are foreseen to encounter a rise in their market share between in the upcoming years.
Allergen Type Outlook and Trend Analysis
On the basis of allergen type the market is segmented into Drug Allergens, Inhaled Allergens and Food Allergens. Diagnosis of hypersensitivities caused by inhaled allergens is foreseen to represent the biggest piece of the overall industry, regarding revenue, over the conjecture time frame. Expanded contamination levels are a main consideration expanding pervasiveness of hypersensitivities caused by inhaled allergens.
Test Type Outlook and Trend Analysis
On the basis of test type the market is segmented into In-vitro and In-vivo. In-vitro test will remain the most beneficial test that is useful for allergy diagnostics across the globe. Revenues from in-vitro test for allergy diagnostics are foreseen to increase at a significant CAGR in the upcoming years.
Regional Outlook and Trend Analysis
On the basis of revenue, North America will remain the biggest market for allergy diagnostics with a significant growth rate in the upcoming years. Development of the market in this locale can be ascribed to variables, for example, better government support, higher healthcare expenditure in the region, and improved medical insurance policies.
Competitive Insights
The leading players in the market are Siemens Healthcare, Lincoln Diagnostics Inc, HOB Biotech Group Co, Hitachi Chemical Company Ltd, Thermo Fisher Scientific India Pvt Ltd, Danaher Corporation, R-Biopharm, Hycor Biomedical Inc and Stallergenes Greer. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
The Allergy Diagnostics Market is segmented as follows-
By Product type:
By End User:
By Allergen Type:
By Test-type:
By Region
Some of the key questions answered by the report are:
Market Classification
Table of Contents
1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Share Analysis
3.3. Market Dynamics
3.3.1. Drivers
3.3.1.1. Rising Environmental Pollution Levels
3.3.1.2. Increasing Access for Allergy Diagnosis Medical Insurance in the US
3.3.1.3. High Incidence and Large Economic Burden of Allergic Diseases
3.3.2. Restraints
3.3.2.1. Low Awareness of Allergic Diseases
3.3.2.2. Issues Related to the Affordability of Allergy Diagnostics Instruments Among Small Laboratories and Physician Clinics
3.3.3. Opportunities
3.3.3.1. Emerging Countries to Offer Lucrative Growth Opportunities
3.4. Industry Trends
4. Allergy Diagnostics Market, By Product Type
4.1. Introduction
4.2. Allergy Diagnostics Market Assessment and Forecast, By Product Type, 2017-2023
4.3. Instruments
4.3.1. Market Assessment and Forecast, By Region, 2017-2023 ($Million)
4.4. Assay Kits
4.4.1. Market Assessment and Forecast, By Region, 2017-2023 ($Million)
4.5. Services
4.5.1. Market Assessment and Forecast, By Region, 2017-2023 ($Million)
4.6. Consumables
4.6.1. Market Assessment and Forecast, By Region, 2017-2023 ($Million)
5. Allergy Diagnostics Market, By End User
5.1. Introduction
5.2. Allergy Diagnostics Market Assessment and Forecast, By End User 2017-2023
5.3. Academic Research Institutes
5.3.1. Market Assessment and Forecast, By Region, 2017-2023 ($Million)
5.4. Diagnostic Laboratories
5.4.1. Market Assessment and Forecast, By Region, 2017-2023 ($Million)
5.5. Hospital
5.5.1. Market Assessment and Forecast, By Region, 2017-2023 ($Million)
5.6. Other End User
5.6.1. Market Assessment and Forecast, By Region, 2017-2023 ($Million)
6. Allergy Diagnostics Market, By Allergan Type
6.1. Introduction
6.2. Allergy Diagnostics Market Assessment and Forecast, By Allergan Type 2017-2023 ($Million)
6.3. Food Allergens
6.3.1. Market Assessment and Forecast, By Region, 2017-2023 ($Million)
6.4. Drug Allergens
6.4.1. Market Assessment and Forecast, By Region, 2017-2023 ($Million)
6.5. Inhaled Allergens
6.5.1. Market Assessment and Forecast, By Region, 2017-2023 ($Million)
6.6. Other Allergens
6.6.1. Market Assessment and Forecast, By Region, 2017-2023 ($Million)
7. Allergy Diagnostics Market, By Test Type
7.1. Introduction
7.2. Allergy Diagnostics Market Assessment and Forecast, By Test Type, 2017-2023 ($Million)
7.3. In-vitro
7.3.1. Market Assessment and Forecast, By Region, 2017-2023 ($Million)
7.4. In-vivo
7.4.1. Market Assessment and Forecast, By Region, 2017-2023 ($Million)
8. Allergy Diagnostics Market, By Region
8.1. Introduction
8.2. Allergy Diagnostics Market Assessment and Forecast, By Region, 2017-2023 ($Million)
8.3. North America
8.3.1. Market Assessment and Forecast, By Country, 2017-2023 ($Million)
8.3.2. Market Assessment and Forecast, By Product Type, 2017-2023 ($Million)
8.3.3. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.3.4. Market Assessment and Forecast, By Allergan Type, 2017-2023 ($Million)
8.3.5. Market Assessment and Forecast, By Test Type, 2017-2023 ($Million)
8.3.5.1. U.S.
8.3.5.1.1. Market Assessment and Forecast, By Product Type, 2017-2023 ($Million)
8.3.5.1.2. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.3.5.1.3. Market Assessment and Forecast, By Allergan Type, 2017-2023 ($Million)
8.3.5.1.4. Market Assessment and Forecast, By Test Type, 2017-2023 ($Million)
8.3.5.2. Canada
8.3.5.2.1. Market Assessment and Forecast, By Product Type, 2017-2023 ($Million)
8.3.5.2.2. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.3.5.2.3. Market Assessment and Forecast, By Allergan Type, 2017-2023 ($Million)
8.3.5.2.4. Market Assessment and Forecast, By Test Type, 2017-2023 ($Million)
8.3.5.3. Mexico
8.3.5.3.1. Market Assessment and Forecast, By Product Type, 2017-2023 ($Million)
8.3.5.3.2. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.3.5.3.3. Market Assessment and Forecast, By Allergan Type, 2017-2023 ($Million)
8.3.5.3.4. Market Assessment and Forecast, By Test Type, 2017-2023 ($Million)
8.4. Europe
8.4.1. Market Assessment and Forecast, By Country, 2017-2023 ($Million)
8.4.2. Market Assessment and Forecast, By Product Type, 2017-2023 ($Million)
8.4.3. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.4.4. Market Assessment and Forecast, By Allergan Type, 2017-2023 ($Million)
8.4.5. Market Assessment and Forecast, By Test Type, 2017-2023 ($Million)
8.4.5.1. Germany
8.4.5.1.1. Market Assessment and Forecast, By Product Type, 2017-2023 ($Million)
8.4.5.1.2. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.4.5.1.3. Market Assessment and Forecast, By Allergan Type, 2017-2023 ($Million)
8.4.5.1.4. Market Assessment and Forecast, By Test Type, 2017-2023 ($Million)
8.4.5.2. France
8.4.5.2.1. Market Assessment and Forecast, By Product Type, 2017-2023 ($Million)
8.4.5.2.2. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.4.5.2.3. Market Assessment and Forecast, By Allergan Type, 2017-2023 ($Million)
8.4.5.2.4. Market Assessment and Forecast, By Test Type, 2017-2023 ($Million)
8.4.5.3. UK
8.4.5.3.1. Market Assessment and Forecast, By Product Type, 2017-2023 ($Million)
8.4.5.3.2. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.4.5.3.3. Market Assessment and Forecast, By Allergan Type, 2017-2023 ($Million)
8.4.5.3.4. Market Assessment and Forecast, By Test Type, 2017-2023 ($Million)
8.4.5.4. Italy
8.4.5.4.1. Market Assessment and Forecast, By Product Type, 2017-2023 ($Million)
8.4.5.4.2. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.4.5.4.3. Market Assessment and Forecast, By Allergan Type, 2017-2023 ($Million)
8.4.5.4.4. Market Assessment and Forecast, By Test Type, 2017-2023 ($Million)
8.4.5.5. Spain
8.4.5.5.1. Market Assessment and Forecast, By Product Type, 2017-2023 ($Million)
8.4.5.5.2. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.4.5.5.3. Market Assessment and Forecast, By Allergan Type, 2017-2023 ($Million)
8.4.5.5.4. Market Assessment and Forecast, By Test Type, 2017-2023 ($Million)
8.4.5.6. Russia
8.4.5.6.1. Market Assessment and Forecast, By Product Type, 2017-2023 ($Million)
8.4.5.6.2. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.4.5.6.3. Market Assessment and Forecast, By Allergan Type, 2017-2023 ($Million)
8.4.5.6.4. Market Assessment and Forecast, By Test Type, 2017-2023 ($Million)
8.4.5.7. Rest of Europe
8.4.5.7.1. Market Assessment and Forecast, By Product Type, 2017-2023 ($Million)
8.4.5.7.2. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.4.5.7.3. Market Assessment and Forecast, By Allergan Type, 2017-2023 ($Million)
8.4.5.7.4. Market Assessment and Forecast, By Test Type, 2017-2023 ($Million)
8.5. Asia-Pacific
8.5.1. Market Assessment and Forecast, By Country, 2017-2023 ($Million)
8.5.2. Market Assessment and Forecast, By Product Type, 2017-2023 ($Million)
8.5.3. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.5.4. Market Assessment and Forecast, By Allergan Type, 2017-2023 ($Million)
8.5.5. Market Assessment and Forecast, By Test Type, 2017-2023 ($Million)
8.5.5.1. Japan
8.5.5.1.1. Market Assessment and Forecast, By Product Type, 2017-2023 ($Million)
8.5.5.1.2. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.5.5.1.3. Market Assessment and Forecast, By Allergan Type, 2017-2023 ($Million)
8.5.5.1.4. Market Assessment and Forecast, By Test Type, 2017-2023 ($Million)
8.5.5.2. China
8.5.5.2.1. Market Assessment and Forecast, By Product Type, 2017-2023 ($Million)
8.5.5.2.2. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.5.5.2.3. Market Assessment and Forecast, By Allergan Type, 2017-2023 ($Million)
8.5.5.2.4. Market Assessment and Forecast, By Test Type, 2017-2023 ($Million)
8.5.5.3. Australia
8.5.5.3.1. Market Assessment and Forecast, By Product Type, 2017-2023 ($Million)
8.5.5.3.2. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.5.5.3.3. Market Assessment and Forecast, By Allergan Type, 2017-2023 ($Million)
8.5.5.3.4. Market Assessment and Forecast, By Test Type, 2017-2023 ($Million)
8.5.5.4. India
8.5.5.4.1. Market Assessment and Forecast, By Product Type, 2017-2023 ($Million)
8.5.5.4.2. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.5.5.4.3. Market Assessment and Forecast, By Allergan Type, 2017-2023 ($Million)
8.5.5.4.4. Market Assessment and Forecast, By Test Type, 2017-2023 ($Million)
8.5.5.5. South Korea
8.5.5.5.1. Market Assessment and Forecast, By Product Type, 2017-2023 ($Million)
8.5.5.5.2. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.5.5.5.3. Market Assessment and Forecast, By Allergan Type, 2017-2023 ($Million)
8.5.5.5.4. Market Assessment and Forecast, By Test Type, 2017-2023 ($Million)
8.5.5.6. Taiwan
8.5.5.6.1. Market Assessment and Forecast, By Product Type, 2017-2023 ($Million)
8.5.5.6.2. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.5.5.6.3. Market Assessment and Forecast, By Allergan Type, 2017-2023 ($Million)
8.5.5.6.4. Market Assessment and Forecast, By Test Type, 2017-2023 ($Million)
8.5.5.7. Rest of Asia-Pacific
8.5.5.7.1. Market Assessment and Forecast, By Product Type, 2017-2023 ($Million)
8.5.5.7.2. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.5.5.7.3. Market Assessment and Forecast, By Allergan Type, 2017-2023 ($Million)
8.5.5.7.4. Market Assessment and Forecast, By Test Type, 2017-2023 ($Million)
8.6. Rest of the World
8.6.1. Market Assessment and Forecast, By Country, 2017-2023 ($Million)
8.6.2. Market Assessment and Forecast, By Product Type, 2017-2023 ($Million)
8.6.3. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.6.4. Market Assessment and Forecast, By Allergan Type, 2017-2023 ($Million)
8.6.5. Market Assessment and Forecast, By Test Type, 2017-2023 ($Million)
8.6.5.1. Brazil
8.6.5.1.1. Market Assessment and Forecast, By Product Type, 2017-2023 ($Million)
8.6.5.1.2. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.6.5.1.3. Market Assessment and Forecast, By Allergan Type, 2017-2023 ($Million)
8.6.5.1.4. Market Assessment and Forecast, By Test Type, 2017-2023 ($Million)
8.6.5.2. Turkey
8.6.5.2.1. Market Assessment and Forecast, By Product Type, 2017-2023 ($Million)
8.6.5.2.2. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.6.5.2.3. Market Assessment and Forecast, By Allergan Type, 2017-2023 ($Million)
8.6.5.2.4. Market Assessment and Forecast, By Test Type, 2017-2023 ($Million)
8.6.5.3. Saudi Arabia
8.6.5.3.1. Market Assessment and Forecast, By Product Type, 2017-2023 ($Million)
8.6.5.3.2. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.6.5.3.3. Market Assessment and Forecast, By Allergan Type, 2017-2023 ($Million)
8.6.5.3.4. Market Assessment and Forecast, By Test Type, 2017-2023 ($Million)
8.6.5.4. South Africa
8.6.5.4.1. Market Assessment and Forecast, By Product Type, 2017-2023 ($Million)
8.6.5.4.2. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.6.5.4.3. Market Assessment and Forecast, By Allergan Type, 2017-2023 ($Million)
8.6.5.4.4. Market Assessment and Forecast, By Test Type, 2017-2023 ($Million)
8.6.5.5. United Arab Emirates
8.6.5.5.1. Market Assessment and Forecast, By Product Type, 2017-2023 ($Million)
8.6.5.5.2. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.6.5.5.3. Market Assessment and Forecast, By Allergan Type, 2017-2023 ($Million)
8.6.5.5.4. Market Assessment and Forecast, By Test Type, 2017-2023 ($Million)
8.6.5.6. Others
8.6.5.6.1. Market Assessment and Forecast, By Product Type, 2017-2023 ($Million)
8.6.5.6.2. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.6.5.6.3. Market Assessment and Forecast, By Allergan Type, 2017-2023 ($Million)
8.6.5.6.4. Market Assessment and Forecast, By Test Type, 2017-2023 ($Million)
9. Company Profiles
9.1. Siemens Healthcare
9.1.1. Business Overview
9.1.2. Product Portfolio
9.1.3. Key Financials
9.1.4. Strategic Developments
9.2. Lincoln Diagnostics Inc.
9.2.1. Business Overview
9.2.2. Product Portfolio
9.2.3. Key Financials
9.2.4. Strategic Developments
9.3. HOB Biotech Group Co.
9.3.1. Business Overview
9.3.2. Product Portfolio
9.3.3. Key Financials
9.3.4. Strategic Developments
9.4. Hitachi Chemical Company Ltd.
9.4.1. Business Overview
9.4.2. Product Portfolio
9.4.3. Key Financials
9.4.4. Strategic Developments
9.5. Thermo Fisher Scientific India Pvt Ltd.
9.5.1. Business Overview
9.5.2. Product Portfolio
9.5.3. Strategic Developments
9.6. Danaher Corporation
9.6.1. Business Overview
9.6.2. Product Portfolio
9.6.3. Strategic Developments
9.7. R-Biopharm
9.7.1. Business Overview
9.7.2. Product Portfolio
9.7.3. Strategic Developments
9.8. Hycor Biomedical Inc.
9.8.1. Business Overview
9.8.2. Product Portfolio
9.8.3. Key Financials
9.8.4. Strategic Developments
9.9. Stallergenes Greer
9.9.1. Business Overview
9.9.2. Product Portfolio
9.9.3. Key Financials
9.9.4. Strategic Developments
List of Tables
Table 1.Global Allergy Diagnostics Market, By Product Type, 2017-2023 ($Million)
Table 2.Instruments Market, By Region, 2017-2023 ($Million)
Table 3.Assay Kits Market, By Region, 2017-2023 ($Million)
Table 4.Services Market, By Region, 2017-2023 ($Million)
Table 5.ConsumablesMarket, By Region, 2017-2023 ($Million)
Table 6.Global Allergy Diagnostics Market, By End User, 2017-2023 ($Million)
Table 7.Academic Research Institutes Market, By Region, 2017-2023 ($Million)
Table 8.Diagnostic Laboratories Market, By Region, 2017-2023 ($Million)
Table 9.Hospital Market, By Region, 2017-2023 ($Million)
Table 10.Other End Users Market, By Region, 2017-2023 ($Million)
Table 11.Global Allergy Diagnostics Market, By Allergan Type, 2017-2023 ($Million)
Table 12.Food Allergens Market, By Region, 2017-2023 ($Million)
Table 13.Drug Allergens Market, By Region, 2017-2023 ($Million)
Table 14.Inhaled Allergens Market, By Region, 2017-2023 ($Million)
Table 15.Other Allergens Market, By Region, 2017-2023 ($Million)
Table 16.Global Allergy Diagnostics Market, By Test Type, 2017-2023 ($Million)
Table 17.In-vitro Market, By Region, 2017-2023 ($Million)
Table 18.In-vivo Market, By Region, 2017-2023 ($Million)
Table 19.North America Allergy Diagnostics Market, By Country, 2017-2023 ($Million)
Table 20.North America Allergy Diagnostics Market, By Product Type, 2017-2023 ($Million)
Table 21.North America Allergy Diagnostics Market, By End User, 2017-2023 ($Million)
Table 22.North America Allergy Diagnostics Market, By Allergan Type, 2017-2023 ($Million)
Table 23.North America Allergy Diagnostics Market, By Test Type, 2017-2023 ($Million)
Table 24.U.S. Allergy Diagnostics Market, By Product Type, 2017-2023 ($Million)
Table 25.U.S. Allergy Diagnostics Market, By End User, 2017-2023 ($Million)
Table 26.U.S. Allergy Diagnostics Market, By Allergan Type, 2017-2023 ($Million)
Table 27.U.S. Allergy Diagnostics Market, By Test Type, 2017-2023 ($Million)
Table 28.Canada Allergy Diagnostics Market, By Product Type, 2017-2023 ($Million)
Table 29.Canada Allergy Diagnostics Market, By End User, 2017-2023 ($Million)
Table 30.Canada Allergy Diagnostics Market, By Allergan Type, 2017-2023 ($Million)
Table 31.Canada Allergy Diagnostics Market, By Test Type, 2017-2023 ($Million)
Table 32.Mexico Allergy Diagnostics Market, By Product Type, 2017-2023 ($Million)
Table 33.Mexico Allergy Diagnostics Market, By End User, 2017-2023 ($Million)
Table 34.Mexico Allergy Diagnostics Market, By Allergan Type, 2017-2023 ($Million)
Table 35.Mexico Allergy Diagnostics Market, By Test Type, 2017-2023 ($Million)
Table 36.Europe Allergy Diagnostics Market, By Country, 2017-2023 ($Million)
Table 37.Europe Allergy Diagnostics Market, By Product Type, 2017-2023 ($Million)
Table 38.Europe Allergy Diagnostics Market, By End User, 2017-2023 ($Million)
Table 39.Europe Allergy Diagnostics Market, By Allergan Type, 2017-2023 ($Million)
Table 40.Europe Allergy Diagnostics Market, By Test Type, 2017-2023 ($Million)
Table 41.Germany Allergy Diagnostics Market, By Product Type, 2017-2023 ($Million)
Table 42.Germany Allergy Diagnostics Market, By End User, 2017-2023 ($Million)
Table 43.Germany Allergy Diagnostics Market, By Allergan Type, 2017-2023 ($Million)
Table 44.Germany Allergy Diagnostics Market, By Test Type, 2017-2023 ($Million)
Table 45.France Allergy Diagnostics Market, By Product Type, 2017-2023 ($Million)
Table 46.France Allergy Diagnostics Market, By End User, 2017-2023 ($Million)
Table 47.France Allergy Diagnostics Market, By Allergan Type, 2017-2023 ($Million)
Table 48.France Allergy Diagnostics Market, By Test Type, 2017-2023 ($Million)
Table 49.UK Allergy Diagnostics Market, By Product Type, 2017-2023 ($Million)
Table 50.UK Allergy Diagnostics Market, By End User, 2017-2023 ($Million)
Table 51.UK Allergy Diagnostics Market, By Allergan Type, 2017-2023 ($Million)
Table 52.UK Allergy Diagnostics Market, By Test Type, 2017-2023 ($Million)
Table 53.Italy Allergy Diagnostics Market, By Product Type, 2017-2023 ($Million)
Table 54.Italy Allergy Diagnostics Market, By End User, 2017-2023 ($Million)
Table 55.Italy Allergy Diagnostics Market, By Allergan Type, 2017-2023 ($Million)
Table 56.Italy Allergy Diagnostics Market, By Test Type, 2017-2023 ($Million)
Table 57.Spain Allergy Diagnostics Market, By Product Type, 2017-2023 ($Million)
Table 58.Spain Allergy Diagnostics Market, By End User, 2017-2023 ($Million)
Table 59.Spain Allergy Diagnostics Market, By Allergan Type, 2017-2023 ($Million)
Table 60.Spain Allergy Diagnostics Market, By Test Type, 2017-2023 ($Million)
Table 61.Russia Allergy Diagnostics Market, By Product Type, 2017-2023 ($Million)
Table 62.Russia Allergy Diagnostics Market, By End User, 2017-2023 ($Million)
Table 63.Russia Allergy Diagnostics Market, By Allergan Type, 2017-2023 ($Million)
Table 64.Russia Allergy Diagnostics Market, By Test Type, 2017-2023 ($Million)
Table 65.Rest of Europe Allergy Diagnostics Market, By Product Type, 2017-2023 ($Million)
Table 66.Rest of Europe Allergy Diagnostics Market, By End User, 2017-2023 ($Million)
Table 67.Rest of Europe Allergy Diagnostics Market, By Allergan Type, 2017-2023 ($Million)
Table 68.Rest of Europe Allergy Diagnostics Market, By Test Type, 2017-2023 ($Million)
Table 69.Asia-Pacific Allergy Diagnostics Market, By Country, 2017-2023 ($Million)
Table 70.Asia-Pacific Allergy Diagnostics Market, By Product Type, 2017-2023 ($Million)
Table 71.Asia-Pacific Allergy Diagnostics Market, By End User, 2017-2023 ($Million)
Table 72.Asia-Pacific Allergy Diagnostics Market, By Allergan Type, 2017-2023 ($Million)
Table 73.Asia-Pacific Allergy Diagnostics Market, By Test Type, 2017-2023 ($Million)
Table 74.Japan Allergy Diagnostics Market, By Product Type, 2017-2023 ($Million)
Table 75.Japan Allergy Diagnostics Market, By End User, 2017-2023 ($Million)
Table 76.Japan Allergy Diagnostics Market, By Allergan Type, 2017-2023 ($Million)
Table 77.Japan Allergy Diagnostics Market, By Test Type, 2017-2023 ($Million)
Table 78.China Allergy Diagnostics Market, By Product Type, 2017-2023 ($Million)
Table 79.China Allergy Diagnostics Market, By End User, 2017-2023 ($Million)
Table 80.China Allergy Diagnostics Market, By Allergan Type, 2017-2023 ($Million)
Table 81.China Allergy Diagnostics Market, By Test Type, 2017-2023 ($Million)
Table 82.Australia Allergy Diagnostics Market, By Product Type, 2017-2023 ($Million)
Table 83.Australia Allergy Diagnostics Market, By End User, 2017-2023 ($Million)
Table 84.Australia Allergy Diagnostics Market, By Allergan Type, 2017-2023 ($Million)
Table 85.Australia Allergy Diagnostics Market, By Test Type, 2017-2023 ($Million)
Table 86.India Allergy Diagnostics Market, By Product Type, 2017-2023 ($Million)
Table 87.India Allergy Diagnostics Market, By End User, 2017-2023 ($Million)
Table 88.India Allergy Diagnostics Market, By Allergan Type, 2017-2023 ($Million)
Table 89.India Allergy Diagnostics Market, By Test Type, 2017-2023 ($Million)
Table 90.South Korea Allergy Diagnostics Market, By Product Type, 2017-2023 ($Million)
Table 91.South Korea Allergy Diagnostics Market, By End User, 2017-2023 ($Million)
Table 92.South Korea Allergy Diagnostics Market, By Allergan Type, 2017-2023 ($Million)
Table 93.South Korea Allergy Diagnostics Market, By Test Type, 2017-2023 ($Million)
Table 94.Rest of Asia-Pacific Allergy Diagnostics Market, By Product Type, 2017-2023 ($Million)
Table 95.Rest of Asia-Pacific Allergy Diagnostics Market, By End User, 2017-2023 ($Million)
Table 96.Rest of Asia-Pacific Allergy Diagnostics Market, By Allergan Type, 2017-2023 ($Million)
Table 97.Rest of Asia-Pacific Allergy Diagnostics Market, By Test Type, 2017-2023 ($Million)
Table 98.Rest of the World Allergy Diagnostics Market, By Country, 2017-2023 ($Million)
Table 99.Rest of the World Allergy Diagnostics Market, By Product Type, 2017-2023 ($Million)
Table 100.Rest of the World Allergy Diagnostics Market, By End User, 2017-2023 ($Million)
Table 101.Rest of the World Allergy Diagnostics Market, By Allergan Type, 2017-2023 ($Million)
Table 102.Rest of the World Allergy Diagnostics Market, By Test Type, 2017-2023 ($Million)
Table 103.Brazil Allergy Diagnostics Market, By Product Type, 2017-2023 ($Million)
Table 104.Brazil Allergy Diagnostics Market, By End User, 2017-2023 ($Million)
Table 105.Brazil Allergy Diagnostics Market, By Allergan Type, 2017-2023 ($Million)
Table 106.Brazil Allergy Diagnostics Market, By Test Type, 2017-2023 ($Million)
Table 107.Turkey Allergy Diagnostics Market, By Product Type, 2017-2023 ($Million)
Table 108.Turkey Allergy Diagnostics Market, By End User, 2017-2023 ($Million)
Table 109.Turkey Allergy Diagnostics Market, By Allergan Type, 2017-2023 ($Million)
Table 110.Turkey Allergy Diagnostics Market, By Test Type, 2017-2023 ($Million)
Table 111.Saudi Arabia Allergy Diagnostics Market, By Product Type, 2017-2023 ($Million)
Table 112.Saudi Arabia Allergy Diagnostics Market, By End User, 2017-2023 ($Million)
Table 113.Saudi Arabia Allergy Diagnostics Market, By Allergan Type, 2017-2023 ($Million)
Table 114.Saudi Arabia Allergy Diagnostics Market, By Test Type, 2017-2023 ($Million)
Table 115.South Africa Allergy Diagnostics Market, By Product Type, 2017-2023 ($Million)
Table 116.South Africa Allergy Diagnostics Market, By End User, 2017-2023 ($Million)
Table 117.South Africa Allergy Diagnostics Market, By Allergan Type, 2017-2023 ($Million)
Table 118.South Africa Allergy Diagnostics Market, By Test Type, 2017-2023 ($Million)
Table 119.United Arab Emirates Allergy Diagnostics Market, By Product Type, 2017-2023 ($Million)
Table 120.United Arab Emirates Allergy Diagnostics Market, By End User, 2017-2023 ($Million)
Table 121.United Arab Emirates Allergy Diagnostics Market, By Allergan Type, 2017-2023 ($Million)
Table 122.United Arab Emirates Allergy Diagnostics Market, By Test Type, 2017-2023 ($Million)
Table 123.Others Allergy Diagnostics Market, By Product Type, 2017-2023 ($Million)
Table 124.Others Allergy Diagnostics Market, By End User, 2017-2023 ($Million)
Table 125.Others Allergy Diagnostics Market, By Allergan Type, 2017-2023 ($Million)
Table 126.Others Allergy Diagnostics Market, By Test Type, 2017-2023 ($Million)
Table 127.Siemens Healthcare Key Strategic Developments, 2017-2017
Table 128.Lincoln Diagnostics Inc.: Key Strategic Developments, 2017-2017
Table 129.HOB Biotech Group Co.: Key Strategic Developments, 2017-2017
Table 130.Hitachi Chemical Company Ltd: Key Strategic Developments, 2017-2017
Table 131.Thermo Fisher Scientific India Pvt Ltd: Key Strategic Developments, 2017-2017
Table 132.Danaher Corporation: Key Strategic Developments, 2017-2017
Table 133.R-Biopharm: Key Strategic Developments, 2017-2017
Table 134.Hycor Biomedical Inc.: Key Strategic Developments, 2017-2017
Table 135.Stallergenes Greer: Key Strategic Developments, 2017-2017
List of Figures
Figure 1.Allergy Diagnostics Market Share, By Product Type, 2017 & 2023 ($Million)
Figure 2.Allergy Diagnostics Market Share, By End User, 2017 & 2023 ($Million)
Figure 3.Allergy Diagnostics Market Share, By Allergan Type, 2017 & 2023 ($Million)
Figure 4.Allergy Diagnostics Market Share, By Test Type, 2017 & 2023 ($Million)
Figure 5.Allergy Diagnostics Market, By Region, 2017 & 2023 ($Million)
Figure 6.Siemens Healthcare: Net Revenues, 2017-2017 ($Million)
Figure 7.Siemens Healthcare: Net Revenue Share, By Segment, 2017
Figure 8.Siemens Healthcare: Net Revenue Share, By Geography, 2017
Figure 9.Lincoln Diagnostics Inc.: Net Revenues, 2017-2017 ($Million)
Figure 10.Lincoln Diagnostics Inc.: Net Revenue Share, By Segment, 2017
Figure 11.Lincoln Diagnostics Inc.: Net Revenue Share, By Geography, 2017
Figure 12.HOB Biotech Group Co: Net Revenues, 2017-2017 ($Million)
Figure 13.HOB Biotech Group Co: Net Revenue Share, By Segment, 2017
Figure 14.HOB Biotech Group Co: Net Revenue Share, By Geography, 2017
Figure 15.Hitachi Chemical Company Ltd: Net Revenues, 2017-2017 ($Million)
Figure 16.Hitachi Chemical Company Ltd: Net Revenue Share, By Segment, 2017
Figure 17.Hitachi Chemical Company Ltd: Net Revenue Share, By Geography, 2017
Figure 18.Stallergenes Greer: Net Revenues, 2017-2017 ($Million)
Figure 19.Stallergenes Greer: Net Revenue Share, By Segment, 2017
Figure 20.Stallergenes Greer: Net Revenue Share, By Geography, 2017
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
Data Collection Matrix |
Supply Side |
Demand Side |
Primary Data Sources |
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
Qualitative Data |
Quantitative Data (2017-2025) |
|
|